“…Cholesterol modulates the activity of a wide range of membrane receptors and ion channels in multiple ways, i.e., via general effects on the bulk bilayer lipid, altering membrane fluidity (el Battari, Ah-Kye, Muller, Sari, & Marvaldi, 1985;Lazar & Medzihradsky, 1992;Maguire & Druse, 1989) or curvature (Lee, 2004;Yesylevskyy, Demchenko, Kraszewski, & Ramseyer, 2013) or through direct binding to these proteins (Baier, Fantini, & Barrantes, 2011;Barrantes, 2004;Dopico & Bukiya, 2014;Fantini & Barrantes, 2013;Levitan, Singh, & Rosenhouse-Dantsker, 2014;Picazo-Juarez et al, 2011;Popot, Demel, Sobel, van Deenen, & Changeux, 1977;Posada et al, 2014;Singh, Shentu, Enkvetchakul, & Levitan, 2011;Rosenhouse-Dantsker, Noskov, Durdagi, Logothetis, & Levitan, 2013;Singh et al, 2012). The availability of the crystal structures of the β2-adrenergic receptor represented an important milestone in the identification of direct interactions between a paradigmatic transmembrane (TM) protein and member of the most abundant and functionally important superfamily of receptors in eukaryotic cells, i.e., the G-protein-coupled receptors (GPCRs) on the one hand and cholesterol (Cherezov et al, 2007;Rosenbaum et al, 2007) on the other.…”